Women who use Depo-Provera or other hormonal birth control pills face a higher risk of developing a slow-growing rare brain ...

Dietary supplements maker Thorne, which moved its business from Idaho to the South Carolina Lowcountry in 2018, could be up ...

Price hikes, cost cuts, and a further pivot toward smokeless products point to Altria Group maintaining its Dividend King ...

The 37-story Pfizer building in midtown was stabilized, after almost falling over earlier this week. Now the real-estate ...

Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes ...

Both McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise ...

The organisation that runs air traffic control in Poland could lose airline fees amounting to over 80% of its income due to a Belgian court ruling in a case brought by U.S.

When two steel columns buckled this week inside the former Pfizer headquarters in midtown Manhattan, the scare prompted ...

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...

Forte Biosciences offers upside as FB102 demonstrates efficacy in celiac disease and vitiligo, suggesting platform potential ...